NYXH · Nasdaq · SIC 3841: Surgical & Medical Instruments & Apparatus · Market Cap: $0.1B · 154 employees
108
SEC Filings
$1.65
Close 2026-08-19
154
Employees
Business Summary
Nyxoah SA is a Belgian medical device company focused on developing and commercializing the Genio system, an implantable neurostimulation device for treating obstructive sleep apnea (OSA) via dual-sided hypoglossal nerve stimulation. The company received CE-Mark certification in Europe in March 2019 and FDA approval in August 2025. First commercial sales occurred in Germany in July 2020 and in the United States in September 2025. In 2025, Nyxoah generated 10.0 million in sales.
Look up NYXH using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on NYXH, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/NYXH (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.